Edges in Network
| Network | GSE16446_top500tf - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | CREBL2 |
| Upstream (Parents) |
|---|
| (<<) ENO1 → CREBL2 |
| (<<) EOMES → CREBL2 |
| (<<) IKZF1 → CREBL2 |
| (<<) FLI1 → CREBL2 |
| (<<) IRF8 → CREBL2 |
| (<<) HCLS1 → CREBL2 |
| (<<) STAT4 → CREBL2 |
| (<<) C5orf41 → CREBL2 |
| (<<) NFATC2 → CREBL2 |
| (<<) YBX1 → CREBL2 |
| (<<) NR3C1 → CREBL2 |
| Downstream (Children) |
|---|
| CREBL2 → PEG3 (>>) |
| CREBL2 → HOPX (>>) |
| CREBL2 → TFAP2A (>>) |
| CREBL2 → MAF (>>) |
| CREBL2 → PITX1 (>>) |
| CREBL2 → BHLHE41 (>>) |
| CREBL2 → IRF6 (>>) |
| CREBL2 → MEOX1 (>>) |
| CREBL2 → BTG2 (>>) |
| CREBL2 → GRHL3 (>>) |
| CREBL2 → TRERF1 (>>) |
| CREBL2 → TCF4 (>>) |
| CREBL2 → FOSL2 (>>) |
| CREBL2 → CEBPA (>>) |
| CREBL2 → SREBF1 (>>) |
| CREBL2 → HHEX (>>) |
| CREBL2 → MEF2C (>>) |
| CREBL2 → CREB3L2 (>>) |
| CREBL2 → BARX1 (>>) |
| CREBL2 → FOSL1 (>>) |
| CREBL2 → ERF (>>) |
| CREBL2 → KDM5B (>>) |
| CREBL2 → MTA3 (>>) |
| CREBL2 → FBXW7 (>>) |
